Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for ZBH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 7.479B
March 31, 2026 7.471B
December 31, 2025 7.695B
September 30, 2025 8.113B
June 30, 2025 7.572B
March 31, 2025 7.176B
December 31, 2024 6.395B
September 30, 2024 6.451B
June 30, 2024 5.835B
March 31, 2024 5.796B
December 31, 2023 5.942B
September 30, 2023 5.482B
June 30, 2023 5.709B
March 31, 2023 5.790B
December 31, 2022 5.864B
September 30, 2022 5.714B
June 30, 2022 6.024B
March 31, 2022 6.301B
December 31, 2021 7.289B
September 30, 2021 7.504B
June 30, 2021 7.852B
March 31, 2021 7.839B
December 31, 2020 8.344B
September 30, 2020 8.290B
June 30, 2020 8.209B
Date Value
March 31, 2020 9.674B
December 31, 2019 8.437B
September 30, 2019 8.555B
June 30, 2019 8.925B
March 31, 2019 9.019B
December 31, 2018 8.939B
September 30, 2018 9.197B
June 30, 2018 9.513B
March 31, 2018 11.11B
December 31, 2017 10.14B
September 30, 2017 10.42B
June 30, 2017 10.68B
March 31, 2017 11.51B
December 31, 2016 11.24B
September 30, 2016 11.58B
June 30, 2016 11.03B
March 31, 2016 11.12B
December 31, 2015 11.50B
September 30, 2015 11.91B
June 30, 2015 12.05B
March 31, 2015 9.061B
December 31, 2014 1.426B
September 30, 2014 1.676B
June 30, 2014 1.687B
March 31, 2014 1.680B

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Intuitive Surgical, Inc. 0.00
Stryker Corp. 15.29B
Globus Medical, Inc. 97.53M
Solventum Corp. 4.78B
Boston Scientific Corp. 12.62B